Neurim Pharmaceuticals Ltd.

AstraZeneca /Sanofi’s Beyfortus (nirsevimab) is on track to become the first preventative option for respiratory syncytial virus (RSV) lower respiratory tract disease in newborns and infants following

The progression of investigational products through a series of increasingly more sophisticated and targeted clinical trials is a well-tried and tested route for the development of new medicines for c

IN VITRO DIAGNOSTICS Financings Biocept Inc. Biocept Inc. (blood-based molecular diagnostics for solid tumors) netted $8.7mm through the sale of 4.3mm common shares at $2.15 (a slight discount) to

IN VITRO DIAGNOSTICS ALLIANCES Akers Biosciences Inc. Alere Inc. First Check Diagnostics LLC Akers Biosciences Inc. licensed Alere Inc. 's First Check Diagnostics LLC exclusive US distribut